Skip to content
About
Our Technology
Science
In the Press
Leadership
Contact Us
Back
Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis
Publication
Author: Arai, et al.
Clinical Cancer Research
Published: 2018
Share this:
LinkedIn
Twitter
Email
Facebook
Cancel
Filter
Done
SELECT TOPIC
Featured
All Types
Brain Cancer
Breast Cancer
Cancer
Clinical Study
Colorectal Cancer
Combination Therapy
Drug Development
Immunotherapy
Kinase Inhibitors
Lung Cancer
Mechanism of Action
Metastatic Cancer
Microdevice
Neuroscience
Ovarian Cancer
Pancreatic Cancer
Personalized Oncology
Rare Cancers
Renal Cancer
Technology Development
Triple-Negative Breast Cancer
SELECT TYPE
All Types
Blog
Podcast
Poster
Presentation
Publication
Video
But first we’d like to learn more about you.
First Name
(Required)
Last Name
(Required)
Email
(Required)
Comments
(Required)
Email
This field is for validation purposes and should be left unchanged.
×
Contact Us
Let’s setup a meeting discuss how we can change the game in oncology treatment.
First Name
(Required)
Last Name
(Required)
Email
Comments
×